Table 4.
The differences between the OS values determined on the basis of the diagnoses, according to the bone marrow involvements detected by PET–CT and bone marrow biopsy
| Diagnosis | Type of ınvolvement | OS* | P** |
|---|---|---|---|
| Hodgkin lymphoma | PET–CT + Biopsy − (n = 9) | 46.9 (11.0–148.0) | |
| PET–CT − Biopsy − (n = 30) | 47.9 (11.0–158.0) | 0.063 | |
| PET–CT + Biopsy + (n = 5) | 13.2 (7.0–27.0) | ||
| PET–CT − Biopsy + (n = 1) | 62.0 (62.0–62.0) | ||
| Follicular lymphoma | PET–CT + Biopsy − (n = 4) | 35.0 (30.0–42.0) | |
| PET–CT − Biopsy − (n = 23) | 36.5 (4.0–103.0) | 0.772 | |
| PET–CT + Biopsy + (n = 6) | 17.5 (4.0–76.0) | ||
| PET–CT − Biopsy + (n = 13) | 35.0 (1.0–74.0) | ||
| DLBCL | PET–CT + Biopsy − (n = 4) | 10.0 (2.0–37.0) | |
| PET–CT– Biopsy − (n = 104) | 36.0 (1.0–107.0) | 0.002 | |
| PET–CT + Biopsy + (n = 7) | 17.0 (0.0–87.0) | ||
| PET–CT − Biopsy + (n = 12) | 12.5 (4.0–60.0) | ||
| NHL (other lymphomas) | PET–CT + Biopsy − (n = 3) | 6.2 (2.0–19.0) | |
| PET–CT − Biopsy − (n = 21) | 19.4 (0.0–93.0) | 0.335 | |
| PET–CT + Biopsy + (n = 18) | 36.6 (1.0–61.0) | ||
| PET–CT − Biopsy + (n = 16) | 35.9 (6.0–84.0) |
* median times were given
** kruskal-wallis test was performed